Apimeds Pharmaceuticals US Statistics
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.05-0.08 (-1.12%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Apimeds Pharmaceuticals US by the numbers
Apimeds Pharmaceuticals US has a market capitalization of $10.6 million based on 1.51M shares outstanding. With trailing EPS of $-35.63, Apimeds Pharmaceuticals US is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 76.1% above its 50-day average and 41.6% below its 200-day average.
Average daily trading volume is 3.36M shares, or about $23.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
APUS valuation vs. peer median
| Metric | APUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.64M | $10.85M | -2% |
| Avg. volume | 3.36M | 65.84K | +5000% |
Peer median across 8 companies: TOVX, ADIL, VTGN, BLRX, CALC, GTBP, KPRX, CMMB.
Valuation
- Market cap
- $10.64M
- EPS (TTM)
- $-35.63
- Shares outstanding
- 1.51M
Price and trading
- Previous close
- 7.13
- Open
- 8.00
- Day range
- 6.86 – 9.84
- 52-week range
- 1.51 – 59.70
- 52-week change
- -58.77%
- Beta
- —
- Volume
- 22.33M
- Average volume
- 3.36M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 10.64M
- Eps
- -35.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.70
- Week52 Low
- 1.51
- Avg Volume
- 3.36M
- Shares Outstanding
- 1.51M
- Ma50
- 4.00
- Ma200
- 12.08
- Pct From52w High
- -88.19%
- Pct From52w Low
- 366.89%